The ephrin-A1 and EphA receptors are frequently highly expressed in different human cancers, suggesting that they may promote tumor development and progression. We generated transgenic mice carrying Fabpl 4xat-132 ephrin-A1, which express ephrin-A1 in the intestinal epithelial cells. Those mice were then mated with Apc min/ þ mice to produce the compound mice, which overexpress ephrin-A1 in the intestinal tumors of Apc min/ þ mice. We compared the number, size and histopathological features of the intestinal tumors in the Fabpl 4xat-132 ephrin-A1/Apc min/ þ compound mice with those of the Apc min/ þ mice. The compound mice showed an increased number of intestinal tumors, significantly in the large intestine, and developed more invasive tumors. Among the 20 mice of each type examined, 5 Apc min/ þ mice developed 5 invasive tumors, 1 invasive tumor in each mouse, in the proximal or middle portions of the small intestine. On the other hand, 14 out of 20 compound mice developed 29 invasive tumors and 16 of them were in the distal small intestine and the large intestine, where transgenic ephrin-A1 was highly expressed. These results suggested that the increased expression of ephrin-A1 accelerated the malignant progression of the intestinal adenoma to invasive tumors.
Introduction
The Eph family is the largest family of receptor tyrosine kinases, which regulates cell adhesion, migration and spatial organization of multicellular tissues (Kullander and Klein, 2002; Surawska et al., 2004; Pasquale, 2005) . These receptors can be subdivided into two classes, EphA and EphB, based on their sequence similarity and binding affinities for their respective ligands. Typically, the EphA receptors bind glycosylphosphatidylinositolanchored ephrin-A ligands, and the EphB receptors bind transmembrane ephrin-B ligands (Eph Nomenclature Committee, 1997) . One of the unique features of the ephrin-Eph system is the ability to elicit a bidirectional signal, that is forward signaling via the Eph receptor kinase activity and reverse signaling via the ephrins (Murai and Pasquale, 2003; Pasquale, 2005) . With the use of an animal cap assay, bidirectional signaling from the ephrin-B-EphB complex was proven to restrict cell intermingling and the suppression of either of the bidirectional signalings contrarily activated the intermingling (Mellitzer et al., 1999) .
The ephrin-A-EphA system and the ephrin-B-EphB system have considerable differences as in carcinogenesis as well. The ephrin-B-EphB system has tumor suppressive functions in many different cancers such as in colon, prostate, breast and so on (Huusko et al., 2004; Batlle et al., 2005; Noren et al., 2006) . On the other hand, expression analyses in human cancer tissues and a murine xenograft model revealed that both ephrin-A1 and EphA2 were highly expressed in the tumor parenchyma and in the tumor vessels in many types of cancers, including urinary bladder, breast, esophagus, uterine cervix, stomach and colon, as well as in aggressive melanomas (Kataoka et al., 2004; Wu et al., 2004; Brantley-Sieders et al., 2005 Nakamura et al., 2005; Straume and Akslen, 2005; Xu et al., 2005; Abraham et al., 2006; Herath et al., 2006) . Furthermore, high expression levels of ephrin-A1 concomitant with EphA2 were reported as a predictor of shorter survival in these cancers. Ephrin-A1 has been reported to be highly expressed in tumor vessels (Ogawa et al., 2000) , and ephrin-A1-Fc fusion proteins have been shown to induce endothelial cell sprouting, migration and assembly in vitro, and vascular remodeling in vivo (Brantley-Sieders et al., 2006) . Therefore, ephrin-A1 is considered to promote tumor progression in vivo by its angiogenic activity. However, accumulated number of studies indicated that ephrin-A1 negatively regulates the protein levels of EphA2 in cultured cells and it suppresses forward signaling-mediated tumor cell growth and invasiveness (Zelinski et al., 2001; Coffman et al., 2003; Nakamura et al., 2005; Liu et al., 2007) .
Colon carcinogenesis is a multistep process involving multiple genetic alterations that regulate cell growth, apoptosis and migration. About 70% of all colorectal cancers show homozygous inactivation of the adenomatous polyposis coli (APC) tumor suppressor gene (Powell et al., 1992) . Thereafter, they accumulate mutations in K-ras, p53, Smad4 and other genes with a progression to an aggressive malignant cancer (Vogelstein, 1990) . Mice carrying the heterozygous Apc mutation spontaneously develop intestinal polyposis (Su et al., 1992) . In the progression stage of carcinogenesis, the tumor cells acquire migrating activity for invasion and metastatic dissemination. Loss of Smad4, Smad2, or EphB2 and EphB3 in the Apc min/ þ mice was reported to accelerate the progression of adenomas to invasive tumors (Takaku et al., 1998; Hamamoto et al., 2002; Batlle et al., 2005) .
In this study, we generated Fabpl 4xat-132 ephrin-A1 transgenic mice, which express ephrin-A1 in the intestinal epithelium, and studied the influence of the intestinal adenomas on the development in the Apc min/ þ mice. We intended to elucidate whether enhanced expression of ephrin-A1 will promote or suppress the malignant progression of the Apc min/ þ mice adenomas.
Results
Generation of Fabpl 4xat-132 ephrin-A1 transgenic mice that express ephrin-A1 transgene in the intestinal mucosa To investigate the potential role of ephrin-A1 in the intestinal epithelium, we constructed an expression plasmid of ephrin-A1 driven under a fatty acid binding protein gene (Fabp)-Fabpl 4xat-132 promoter, which was reported to induce the expression of a connected gene throughout the mucosal epithelium in the distal small intestine and the large intestine, preferentially in the terminally differentiated cells (Simon et al., 1997; Saam and Gordon, 1999) . We injected the linearlized Fabpl 4xat-132 ephrin-A1 fragment ( Figure 1a ) into fertilized eggs and established two lines of transgenic mice (lines 13 and 47). Reverse transcriptase-PCR (RT-PCR) studies indicated that mRNA of the ephrin-A1 transgene was highly expressed in the distal small intestine and the large intestine (Figure 1b) .
The expression of the ephrin-A1 protein was then assessed by immunohistochemistry. The frozen sections from the intestinal tissues of both the wild-type and the transgenic mice were stained for ephrin-A1. The Fabpl 4xat-132 ephrin-A1 transgenic mice had clear staining for ephrin-A1 in the intestinal epithelium in the villous regions from middle to distal parts of the small intestine and the surface regions of the large intestine ( Figure 1c ). We also found some cells that were positive for ephrin-A1 scattered in the crypts, not only in the transgenic mice but also in the wild-type mice (Figure 1c ). To confirm that these were enteroendocrine cells, serial frozen sections were stained for ephrin-A1 and chromogranin A (CGA). Furthermore, the sections stained for ephrin-A1 were bleached and restained with Grimelius staining (Figure 2 ). The cells expressing ephrin-A1 overlapped with the cells positive for CGA (Figure 2a , yellow arrows) and Grimelius ( Figure 2b , black arrows). About half of Grimelius-positive enteroendocrine cells were positive for ephrin-A1. Specificity of the staining for ephrin-A1 was confirmed by an absorption test (Supplementary Figure 1) . The Fabpl 4xat-132 ephrin-A1 transgenic mice were normal in both macroscopic and histological observations and did not develop tumors, at least up to 1.5 years of age.
Effects of ephrin-A1 transgene expression on the number and size of intestinal tumors in Apc min/ þ mice We next examined whether the overexpression of ephrin-A1 affected the progression of tumors in the Apc min/ þ mice. For this purpose, we generated the compound mice, which carried both the Fabpl . The ephrin-A1 transgenic mice and the compound mice had a higher expression of endogenous ephrin-A1 than the wild-type mice and the Apc min/ þ mice ( Figure 3a ). To our surprise, we also detected that the mRNA expression of EphA2, the main receptor of ephrin-A1 in the intestinal mucosa, was not decreased in the transgenic mice and the compound mice. It was rather increased similar to the endogenous ephrin-A1. Expression of EphB2 was not affected in these tumors. Immunohistochemical examination revealed patchy staining of ephrin-A1 and EphA2 in the different parts of adenoma cells of the compound mice (Figures 3b and c) . It was within detectable levels in the adenoma of Apc min/ þ mice. The compound mice became moribund at the same age, as did the Apc min/ þ mice. However, the number of tumors in the large intestine from the compound mice were increased at both 12 and 20 weeks after birth. The compound mice at 20 weeks developed 5.1 ± 2.5 polyps per mouse in the large intestine, while Apc min/ þ mice developed 1.7±1.1 polyps (Table 1 , n ¼ 15, Po0.001). The average size of tumors was not statistically different between the compound mice and Apc min/ þ mice. However, the number of polyps larger than 4 mm in diameter in the large intestine from the 20-week-old compound mice was 1.9 ± 1.3, and for Apc min/ þ mice, it was 0.6 ± 0.5 (n ¼ 15, Po0.01). The number of polyps larger than 4 mm in diameter in the distal small intestine was 4 times more in the compound mice than in the Apc min/ þ mice at 20 weeks (Table 1) . Five compound mice developed a total of 6 invasive tumors in the distal small intestine and six compound mice had 10 invasive tumors in the large intestine, where the ephrin-A1 transgene was highly expressed. On the other hand, no invasive tumors were found in those regions of the Apc min/ þ mice. The Apc min/ þ mice had invasive tumors in the proximal and middle intestine, the incidence of which did not differ significantly from that of the compound mice.
We carefully examined the invasive growth of the tumors by immunohistochemistry using b-catenin and a-smooth muscle actin antibodies. The representative invasive figures are shown in Figure 4 . An early invasive tumor in Figures 4a-d showed invasion of small clusters of tumor cells through a fissure of mucosal muscle layer. Small numbers of a-smooth muscle actin-positive myofibroblasts were found around the tumor cells. On the other hand, non-invasive tumor of the Apc min/ þ mice kept continuity of the underneath mucosal muscle layer and did not accompany activation of stroma cells in the submucosal tissue (Figures 4e and f) . Advanced invasive tumor formed well-differentiated tubular structures, destroyed normal intestinal architecture and accompanied desmoplastic stromal tissue containing plenty of myofibroblasts and tumor vessels (Figures 4g-j) .
Discussion
Our results demonstrated that the enhanced expression of ephrin-A1 in the intestinal epithelium accelerated the intestinal tumorigenesis in the Apc min/ þ background (Table 1) . Furthermore, the enhanced expression of Ephrin-A1 activates invasion of Apc min/ þ adenoma L Shi et al ephrin-A1 increased the incidence of invasive tumors (Table 2, Supplementary Table 1) . These results are consistent with previous studies that reported that the overexpression of ephrin-A1 activates the migration of colon carcinoma cells in vitro (Potla et al., 2002) , the upregulation of ephrin-A1 correlated with the invasiveness and metastatic potential of the breast cancer cell lines (Yang et al., 2004) and that the suppression of Eph signaling through interference with soluble EphA2-Fc inhibits angiogenesis, tumor growth and metastasis in an orthotopic pancreatic ductal adenocarcinoma model in mice (Dobrzanski et al., 2004) .
On the other hand, several reports suggested that ephrin-A1 reduces malignant potentials of cultured cancer cells. Ephrin-A1-Fc reduced the growth of bladder cancer cells, which overexpress EphA2 (Abraham et al., 2006). In addition, agonistic antibody against EphA2 resulted in the activation and degradation of EphA2 to regress tumors in vivo (Coffman et al., 2003) . These inconsistent findings could be the result of balance between activation and degradation of EphA2 induced by ligand binding on EphA2. Parri et al. (2005) reported that low-molecular-weight protein-tyrosine phosphatase (LMW-PTP) binds to EphA2 that is activated by ligand binding and dephosphorylates EphA2 in PC3 cells. Ephrin-A1 suppressed proliferation and migration of this cell line. Degradation of EphA2 by its ligand binding was also described in gastric cancer cell lines and the involvement of Cbl was documented in the degradation (Wang et al., 2002; Nakamura et al., 2005) . In our models, transgenic expression of ephrin-A1 increased the endogenous ephrin-A1 and EphA2 in mosaic patterns. The cells highly positive for ephrin-A1 did not overlap with cells highly expressing EphA2. We 
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do not know the mechanism of this phenomenon, but it is the conspicuous difference with the above-mentioned models in which ephrin-A1 suppressed tumor formation and invasiveness. Enhanced expression of ephrin-A1 in the presence of EphA2 is considered to activate invasion, probably through EphA2-mediated forward signaling. But in some cases, EphA2 is downregulated and invasiveness may be decreased. It remains to be elucidated how both the deletion of EphB receptors and overexpression of EphA receptors accelerate the progression of tumors. The complicated functions of the ephrin-Eph system on cell intermingling and spatial organization of multicellular tissues may be the result of its unique bidirectional forward and reverse signaling (Mellitzer et al., 1999; Pasquale, 2005) . So far, unidirectional forward signaling that is activated by EphA-ephrin-A system seems to activate invasion, and bidirectional signaling through EphB-ephrin-B complex inhibits invasive activity. We confirmed that EphB2 was not downregulated in the intestinal tumors in the compound mice (Figure 3a) .
Thirty percent of randomly selected colorectal carcinomas are reported to have an enteroendocrine phenotype and are positive for CGA. The CGA-positive tumors tended to be more aggressive than the CGAnegative tumors (de Bruine et al., 1993; Swatek and Chibowski, 2000) . In our present observation, the enteroendocrine cells frequently expressed ephrin-A1 (Figure 2 ). Tumor cells of the compound mice did not express CGA (Supplementary Figure 2) , suggesting that high expression of ephrin-A1 is a characteristic of enteroendocrine cells but it is not an inducer of enteroendocrine differentiation. Present new findings suggest that ephrin-A1 could be involved in the aggressive nature of colorectal carcinoma with the endocrine phenotype.
Materials and methods

DNA construction
A transgene Fabpl 4xat-132 ephrin-A1 was created by the insertion of the full coding sequence of human ephrin-A1 into the PBSdBam/colon/hGHno 78 vector, which contains the mouse Fabpl 4xat-132 promoter (Simon et al., 1997; Saam and Gordon, 1999) .
Screening of Fabpl
4xat-132 ephrin-A1 transgenic mice and Apc min/ þ mice All animal experiments were carried out after receiving approval from the Institutional Animal Experiment Committee of the University of Tsukuba, and in accordance with the regulation for animal experiments in our university and with the fundamental guidelines for the proper conduct of animal experiments and related activities in academic research institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology. The Fabpl 4xat-132 ephrin-A1 transgenic mice were established by using the standard techniques of pronuclear injections. The obtained transgenic animals were mated with the Apc min/ þ mice to generate the Fabpl 4xat-132 ephrin-A1/Apc min/ þ compound mice. All the lines of mice were maintained in a C57BL/6 background. The genomic screening of the tail DNA was performed by PCR using the following primers:
Fabpl 4xat-132 ephrin-A1 transgene, forward primer (F) 5 0 -TCGTTGACCATTGCTCTCAG-3 0 ; reverse primer (R) 5 0 -CCACCAGGTACAG TATGTA-3 0 ; wild-type and min alleles 
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0 -TGATACTTCTTCCAAAGCTTTGGC TAT-3 0 ; (R) 5 0 -TCTCGTTCTGAGAAAGACAGAAGCT-3 0 . The wild-type and min alleles were identified by digestion of the PCR products with HindIII as previously reported (Luongo et al., 1994) .
RNA extraction and reverse transcriptase-PCR
The murine tissue specimens were snap-frozen in liquid nitrogen and stored at À80 1C until use. The total RNA was extracted using an RNeasy Mini kit (QIAGEN Science, Germantown, MD, USA) following the manufacturer's recommendations. The first strand cDNA was synthesized using a cDNA synthesis kit 1 (TAKARA Bio., Otsu, Japan). For PCR amplification of the gene products, the following primers were used:
Generation and examination of Fabpl 4xat-132 ephrin-A1/Apc min/ þ compound mice The Fabpl 4xat-132 ephrin-A1/Apc min/ þ compound mice and the littermates of the Apc min/ þ mice were examined at 12 or 20 weeks after birth. The intestinal tissue from each mouse was opened along the longitudinal axis, and fixed in 12% buffered formalin for 24 h at room temperature. For the easier identification of tumors, the fixed intestines were stained with 0.5% methylene blue. The tumors were counted and measured under a dissection microscope. L-I Apc 0 1.0 ± 1.0 1.7 ± 1.5 0.7 ± 0.6 0 0 3.3 ± 2.1* 2.4 ± 1.4 Com 0 0 1.3 ± 0.0 0.3 ± 0.6 0.3 ± 0.6 0 1.7 ± 0.6 3.1 ± 0.5
weeks
Pro-SI Com 0 1.1 ± 1.0 1.6 ± 1.1 1.9 ± 1.4 1.1 ± 1.0 0 5.7 ± 2.4 3.0 ± 1.6 Apc 0 1.1 ± 1.1 2.2 ± 1.4 1.6 ± 1.1 0.3 ± 0.5 0.1 ± 0.3 5.8 ± 2.5 2.9 ± 1.3 Dis-SI Com 0 8.5 ± 4.8 19.1 ± 5.4 7.1 ± 2.7 1.9 ± 2.1 0.5 ± 0.8 37.0 ± 8.9 2.6 ± 0.4 Apc 0 7.0 ± 3.4 21.1 ± 9.2 5.6 ± 1.9 0.6 ± 0.7 0 33.0 ± 9.7 2.5 ± 0.2 L-I Com 0 0.3 ± 0.5 1.8 ± 1.5 1.1 ± 1.0 1.5 ± 0.7 0.4 ± 0.6 5.1 ± 2.5** ] 3.5 ± 0.9 Apc 0 0.1 ± 0.3 0.3 ± 0.6 0.6 ± 0.6 0.5 ± 0.8 0.1 ± 0.3 1.7 ± 1.1 3.4 ± 0.9
Abbreviations: Dis-SI, distal one-third of the small intestine; LI, large intestine. Mid-SI, middle one-third of the small intestine; Pro-SI, proximal one-third of the small intestine. *P ¼ 0.064, **Po0.001. Immunohistochemical staining for a-smooth muscle actin. Representative tumor cells with diffuse cytoplasmic and nuclear staining for b-catenin (c) in the distal small intestine of a 20-week-old compound mouse invade through a fissure of the mm stained for a-smooth muscle actin (d). Non-invasive tumor in an Apc min/ þ mouse (e) is in the mucosal layer on the continuous mm layer (f, arrows). Advanced invasive tumors (g, h and i) in the large intestine of a 20-week-old compound mouse accompany massive stromal tissues with tumor vessels and a-smooth muscle actin-positive myofibroblasts (j). mm, mucosal muscle.
Ephrin-A1 activates invasion of Apc min/ þ adenoma L Shi et al rabbit anti-human chromogranin A (DakoCytomation, Carpinteria, CA, USA). The sections stained for ephrin-A1 were bleached and restained by Grimelius silver staining to detect enteroendocrine cells. The paraffin-embedded tissues were sectioned at 3 mm thickness, deparaffinized in xylene, rehydrated in graded ethanol solution and immersed in citrate-NaOH buffer (10 mM sodium citrate, pH 7.2) for 20 min at 115 1C, 121 kPa for restoration of antigenicity. The rehydrated sections were stained with hematoxylin and eosin, or incubated overnight at 4 1C with mouse anti-a-smooth muscle antibody (Sigma, St Louis, MO, USA) or mouse anti-b-catenin antibody (BD Transduction Laboratories, Franklin Lakes, NJ, USA). The sections incubated with the first antibodies were washed with phosphate-buffered saline and subsequently colored using the Dako EnVision system/HRP (DAB) (DakoCytomation, Carpinteria, CA, USA).
Statistical analysis
The statistical analyses of the results were performed using STDEV and Student's t-test. A value of P%0.05 was considered to be statistically significant.
